Trial Summary
What is the purpose of this trial?
This 2-site effectiveness trial will test whether a brief dissonance-based obesity prevention program delivered in single sex groups combined with food response and attention training will produce significantly larger weight gain prevention effects than an educational video control condition. An effectiveness trial is important to test whether this program reduces risk for unhealthy weight gain when delivered by real world clinicians under ecologically valid conditions, which is an important step toward broad implementation. A secondary aim focuses on eating disorder symptom prevention effects. A sample of 17-20 year olds with weight concerns (N = 120) will be randomized to single sex Project Health groups with food response and attention training or an educational video control condition. Participants will complete assessments at baseline, posttest, and 6- and 12-month follow ups.
Research Team
Eric Stice, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for 17-20 year olds who are concerned about their weight, believe they can improve their diet and exercise habits, and have a BMI between 20 to 30. It's not for those with anorexia, bulimia, binge eating disorder or past participants in Project Health studies.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Project Health (Behavioral Intervention)
- Response and Attention Training (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Research Institute
Lead Sponsor
Michael Holmes
Oregon Research Institute
Chief Executive Officer since 2023
PhD in Behavioral Sciences
Carol Metzler
Oregon Research Institute
Chief Medical Officer since 2013
PhD in Behavioral Sciences
Drexel University
Collaborator
Nancy D. Spector
Drexel University
Chief Medical Officer
MD from Drexel University
Denis O'Brien
Drexel University
Chief Executive Officer since 2020
MBA from Drexel University
Stanford University
Collaborator
Dr. Richard A. Miller
Stanford University
Chief Executive Officer since 2023
Stanford University, MD
Dr. Robert Schott
Stanford University
Chief Medical Officer since 2021
University of Michigan, MD